Radu O Minea
6PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 16, 2025
Potent Therapeutic Activity of NEO212 in Preclinical Models of Human and Canine Leukaemia and Lymphoma.Thomas C Chen, Steve Swenson, Thu Zan Thein
|Jul 18, 2024
NEO212, temozolomide conjugated to NEO100, exerts superior therapeutic activity over temozolomide in preclinical chemoradiation models of glioblastoma.Radu O Minea, Thu Zan Thein, Zhuoyue Yang
|Mar 13, 2024
Activation of Epstein-Barr Virus' Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and Temozolomide.Hannah Hartman-Houstman, Steve Swenson, Radu O Minea
|Aug 07, 2023
Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a perillyl alcohol-rolipram conjugate.Mengting Ou, Hee-Yeon Cho, Jie Fu
|Dec 23, 2022
NEO212, a Perillyl Alcohol-Temozolomide Conjugate, Triggers Macrophage Differentiation of Acute Myeloid Leukemia Cells and Blocks Their Tumorigenicity.Thomas C Chen, Radu O Minea, Steve Swenson
|Sep 04, 2020
Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas.Radu O Minea, Tuan Cao Duc, Stephen D Swenson
Pageof 1
